Related Experiment Video
Updated: May 27, 2026

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients
Jonas Alex Morales Saute1, Andrew Chaves Feitosa da Silva, Gabriele Nunes Souza
1Postgraduate Program in Medical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
Abstract:
Spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/MJD), is an autosomal dominant neurodegenerative disorder with no current treatment. We aimed to evaluate the body mass index (BMI) of patients with SCA3/MJD and to assess the correlations with clinical, molecular, biochemical, and neuroimaging findings. A case-control study with 46 SCA3/MJD patients and 42 healthy, non-related control individuals with similar age and sex was performed. Clinical evaluation was done with the ataxia scales SARA and NESSCA. Serum insulin, insulin-like growth factor 1 (IGF-1) and magnetic resonance imaging normalized volumetries of cerebellum and brain stem were also assessed. BMI was lower in SCA3/MJD patients when compared to controls (p = 0.01). BMI was associated with NESSCA, expanded CAG repeat number (CAG)n, age of onset, age, disease duration, and serum insulin levels; however, in the linear regression model, (CAG)n was the only variable independently associated with BMI, in an inverse manner (R = -0.396, p = 0.015). In this report, we present evidence that low BMI is not only present in SCA3/MJD, but is also directly related to the length of the expanded CAG repeats, which is the causative mutation of the disease. This association points that weight loss might be a primary disturbance of SCA3/MJD, although further detailed analyses are necessary for a better understanding of the nutritional deficit and its role in the pathophysiology of SCA3/MJD.
Insights
Body mass index (BMI) is lower in patients with Spinocerebellar ataxia type 3 (SCA3/MJD). Lower BMI in SCA3/MJD is directly linked to the length of the expanded CAG repeat, suggesting weight loss may be a primary disease disturbance.
Area of Science:
- Neurodegenerative diseases
- Genetics and molecular biology
- Biochemistry and metabolism
Background:
- Spinocerebellar ataxia type 3 (SCA3/MJD) is a fatal autosomal dominant neurodegenerative disorder.
- Currently, no effective treatments exist for SCA3/MJD.
- Understanding disease mechanisms, including metabolic changes, is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate body mass index (BMI) in SCA3/MJD patients.
- To explore correlations between BMI and clinical, molecular, biochemical, and neuroimaging markers.
- To identify factors associated with BMI variations in SCA3/MJD.
Main Methods:
- A case-control study comparing 46 SCA3/MJD patients with 42 healthy controls.
- Clinical assessments using SARA and NESSCA ataxia scales.
- Measurement of serum insulin, IGF-1, and volumetric MRI of the cerebellum and brainstem.
Main Results:
- SCA3/MJD patients exhibited significantly lower BMI compared to controls (p=0.01).
- BMI was associated with NESSCA scores, CAG repeat length, age of onset, disease duration, and serum insulin.
- Linear regression identified expanded CAG repeat length as the sole independent predictor of lower BMI (R=-0.396, p=0.015).
Conclusions:
- Low BMI is a characteristic finding in SCA3/MJD.
- The inverse relationship between BMI and CAG repeat length suggests a direct molecular link.
- Weight loss may represent a primary pathophysiological feature of SCA3/MJD, warranting further investigation.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019